Medical Journals

Interleukin-17 Receptor-like Gene is a Novel Antiapoptotic Gene Highly Expressed in Androgen-independent Prostate Cancer.

Authors:
  • You Zongbing
  • Shi Xu-Bao
  • DuRaine Grayson
  • Haudenschild Dominik
  • Tepper Clifford G
  • Lo Su Hao
  • Gandour-Edwards Regina
  • de Vere White Ralph W
  • Reddi A Hari

From: Center for Tissue Regeneration and Repair, Department of Orthopaedic Surgery, School of Medicine, University of California, Davis, Sacramento, California 95817, USA. zyou@ucdavis.edu

Cancer research

  • Publish Date: Jan 2006
  • ISSN: 0008-5472
  • Volume: 66
  • Issue: 1
  • Pages: 175-83
  • Medium: Print
  • Language: English
  • Citation (JAMA): You Zongbing, Shi Xu-Bao, DuRaine Grayson, et al. Interleukin-17 Receptor-like Gene is a Novel Antiapoptotic Gene Highly Expressed in Androgen-independent Prostate Cancer.. Cancer Res. Jan 2006;66:175-83

Abstract

We have recently identified a new gene, interleukin-17 receptor-like (IL-17RL), which is expressed in normal prostate and prostate cancer. This investigation is focused on the role of IL-17RL in prostate cancer. We found that IL-17RL was expressed at significantly higher levels in several androgen-independent prostate cancer cell lines (PC3, DU145, cds1, cds2, and cds3) and tumors compared with the androgen-dependent cell lines (LNCaP and MLC-SV40) and tumors. In an in vivo model of human prostate tumor growth in nude mice (CWR22 xenograft model), IL-17RL expression in tumors was induced by androgen deprivation. The relapsed androgen-independent tumors expressed higher levels of IL-17RL compared with the androgen-dependent tumors. Overexpression of IL-17RL in tumor necrosis factor alpha (TNFalpha)-sensitive LNCaP cells inhibited TNFalpha-induced apoptosis by blocking activation of caspase-3 downstream to caspase-2 and caspase-8. Reciprocally, knocking down IL-17RL expression by small interfering RNA induced apoptosis in all the prostate cancer cell lines studied. Taken together, these results show that IL-17RL is a novel antiapoptotic gene, which may confer partially the property of androgen-independent growth of prostate cancer by promoting cell survival. Thus, IL-17RL is a potential therapeutic target in the treatment of prostate cancer.

Mesh Headings (Keywords): Animals, Apoptosis, Caspases, Cell Adhesion, Cell Line, Tumor, Drug Resistance, Neoplasm, Enzyme Activation, Extracellular Matrix, Humans, Isoenzymes, Male, Mice, Mice, Nude, Neoplasms, Hormone-Dependent, Prostatic Neoplasms, RNA, Small Interfering, Receptors, Interleukin, Tumor Necrosis Factor-alpha


Check for Full Text / PubMed Unique Identifier (PMID): 16397230


This abstract is part of PubMed, a service of the U.S. National Library of Medicine. PubMed includes more than 17 million citations from MEDLINE and other life science journals for biomedical articles. See Copyright and Disclaimers.

Linked medical terms appearing on this page are added by Healia to help readers find more information and are not part of the original PubMed document.

The data herein was last updated on July 8th, 2008 and may not reflect the most current and accurate data available from NLM.


Advertisements

About | Privacy Policy | Business Solutions | Advertise | Contact | Add Healia to your site

©2012. Healia / Meredith Corporation  

Use of this site constitutes acceptance of our Terms of Service and Privacy Policy. All content on this Web site, including medical opinion and any other health-related information, is for informational purposes only and should not be used for a specific diagnosis or individual treatment plan for any situation. Use of this site and the information contained herein does not create a doctor-patient relationship. Always seek the direct advice of your doctor in connection with any questions or issues you may have regarding your own health or the health of others.